Heyman Richard A.
SEC insider (Form 3/4/5 filer). CIK 0001584759. Director at Oric Pharmaceuticals, Inc. (ORIC) and 2 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Heyman Richard A. has filed insider reports for
- Oric Pharmaceuticals, Inc. (ORIC): Director
- Enliven Therapeutics, Inc. (ELVN): Director
- PMV Pharmaceuticals, Inc. (PMVP): Director
Heyman Richard A.
CIK: 0001584759
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Oct 1, 2026ORIC
Oric Pharmaceuticals, Inc.
SaleDirect3.5K shares at avg. $12.91$45K - Oct 1, 2026ORIC
Oric Pharmaceuticals, Inc.
ExerciseDirect3.5K shares at avg. $1.60$6K - Oct 1, 2026ORIC
Oric Pharmaceuticals, Inc.
SaleIndirect3.2K shares at avg. $12.91$41K - Jul 24, 2026ORIC
Oric Pharmaceuticals, Inc.
SaleIndirect6.1K shares at avg. $12.02$73K - Jul 24, 2026ORIC
Oric Pharmaceuticals, Inc.
SaleDirect7K shares at avg. $12.02$84K - Jul 24, 2026ORIC
Oric Pharmaceuticals, Inc.
ExerciseDirect3.5K shares at avg. $1.60$6K - Jul 6, 2026ORIC
Oric Pharmaceuticals, Inc.
SaleIndirect300 shares at avg. $12.00$4K - Feb 17, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect1.2K shares at avg. $26.18$32K - Feb 12, 2026ELVN
Enliven Therapeutics, Inc.
AwardDirectStock Option (right to buy)
19.2K shares- - Jan 20, 2026ELVN
Enliven Therapeutics, Inc.
SaleIndirect718 shares at avg. $26.96$19K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  ORIC Oric Pharmaceuticals, Inc. | Sale | 3,500 | $12.91 | $45,199 | Direct |
| Oct 1, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise | 3,500 | $1.60 | $5,600 | Direct |
| Oct 1, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale | 3,200 | $12.91 | $41,325 | Indirect |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale | 6,100 | $12.02 | $73,322 | Indirect |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale | 7,000 | $12.02 | $84,140 | Direct |
| Jul 24, 2026 | ORIC Oric Pharmaceuticals, Inc. | Exercise | 3,500 | $1.60 | $5,600 | Direct |
| Jul 6, 2026 | ORIC Oric Pharmaceuticals, Inc. | Sale | 300 | $12.00 | $3,600 | Indirect |
| Feb 17, 2026 |  ELVN Enliven Therapeutics, Inc. | Sale | 1,230 | $26.18 | $32,196 | Indirect |
| Feb 12, 2026 | ELVN Enliven Therapeutics, Inc. | Award Stock Option (right to buy) | 19,234 | - | - | Direct |
| Jan 20, 2026 | ELVN Enliven Therapeutics, Inc. | Sale | 718 | $26.96 | $19,354 | Indirect |
1-10 of 28 transactions